Companies To Pay $1.25B Over Opioid Suits In West Virginia
Companies To Pay $1.25B Over Opioid Suits In West Virginia
Introduction
In a proposed settlement, Communities in West Virginia said that they would get $1.25 billion from the defendants, which would help end most of the litigation stemming from the opioid crisis in the state.
The companies are looking forward to settling about 3000 lawsuits nationwide. The deal is said to be one of its kind, which will make drug makers, distribution companies, and pharmacies pay for fuelling the opioids epidemic in the country resulting in 4,30,000 deaths in the U.S. since 2000.
Paul Farrell, a West Virginia-based lawyer who is one of the leaders in the lawsuits nationwide, announced that West Virginia wants to settle the deal separately as they might get excluded from the $18 billion national settlement, which includes three dominant distribution companies, AmerisourceBergen, Cardinal Health, and McKesson. Farrell notified that even though the deal is confirmed, establishing a panel is necessary for further proceedings.
The settlement will include three major distributors along with Johnson & Johnson, and Teva. But it will not include the two key drug makers, Purdue Pharma and Mallinckrodt, as they both are trying to make a settlement in the bankruptcy court.
Meanwhile, Clinton County commissioners will be mulling over until Friday to decide whether to drop their individual lawsuit against the opioid industry and join other local Ohio governments to group-negotiate a potential settlement. The Commissioners President Kerry R. Steed said the State of Ohio believes political jurisdiction will be stronger together than individually, and so the State is making a case to bundle together individual lawsuits around Ohio.
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…